Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:36 AM
Ignite Modification Date:
2025-12-25 @ 12:36 AM
NCT ID:
NCT03359967
Eligibility Criteria:
Inclusion Criteria:
Patients will eligible if they had already taking Sacubitril/Valsartan for ≥2 weeks and had been implanted with CIED for ≥3 months. Additionally, eligible patients must have a CIED before Sacubitril/Valsartan prescription date.
Exclusion Criteria:
* Patients younger than 18 years.
* Patients who not taking or taking \<2 weeks Sacubitril Valsartan
* Patients who had a CIED which not using OptiVol algoritm for impedance measurement.
* Patients with structural pulmonary disease
* Patients with obstructive sleep apnea syndrome who using a continuous positive airway pressure device
* Patients with CIED pocket abcess
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03359967
Study Brief:
Protocol Section:
NCT03359967